XML 58 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Schedule of warrants (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Net Investment Income [Line Items]  
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance | shares 3,779,243
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price $ 5.89
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted | shares 1,590,150
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price $ 3.14
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations | shares (101,679)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price $ 7.20
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance | shares 5,267,714
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price $ 5.03
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 3 years 4 months 24 days
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number | shares 3,712,506
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price $ 5.79
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms 2 years 7 months 6 days
Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1 | $ [1]
Warrant [Member]  
Net Investment Income [Line Items]  
Exercise price (in dollars per share) $ 1.96
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $1.96 for our common stock on June 30, 2022.